Acurx Pharmaceuticals (ACXP) Shares Issued (2021 - 2026)
Acurx Pharmaceuticals' (ACXP) quarterly Shares Issued came in at $214101.0 in Q1 2026, down 94.35% YoY from $3.8 million in Q1 2025, and down 6.0% on a QoQ basis from $227775.0 in Q4 2025.
Acurx Pharmaceuticals (ACXP) Shares Issued (2021 - 2026) Analysis & Trends
Acurx Pharmaceuticals (ACXP) has 6 years of Shares Issued data on file, last reported at $214101.0 in Q1 2026.
- Quarterly Shares Issued fell 94.35% year-over-year to $214101.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $214101.0 (down 94.35% YoY) and the FY2025 annual result came in at $227775.0, up 17.41% from the prior year.
- Shares Issued declined to $214101.0 in Q1 2026, from $227775.0 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $3.9 million in Q2 2024 to a low of $194000.0 in Q4 2024.
- A 5-year average of $1.8 million and a median of $1.7 million in 2023 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2024 — Shares Issued jumped 103.85% — and 2026, when it tumbled 94.35%.
- Tracing ACXP's Shares Issued over 5 years: stood at $2.5 million in 2022, then gained by 20.97% to $3.0 million in 2023, then sank by 93.5% to $194000.0 in 2024, then climbed by 17.41% to $227775.0 in 2025, then dropped by 6.0% to $214101.0 in 2026.
- The last three Shares Issued figures came in at $214101.0 (Q1 2026), $227775.0 (Q4 2025), and $227775.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Acurx Pharmaceuticals | 6.18 Mn | 6.18 Mn | - | 348,625.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 348,625.00 |
| Jun 30, 2026 | 348,625.00 |
| Mar 31, 2026 | 214,101.00 |
| Mar 31, 2026 | 214,101.00 |
| Dec 31, 2025 | 227,775.00 |
| Dec 31, 2025 | 227,775.00 |
| Sep 30, 2025 | 227,775.00 |
| Sep 30, 2025 | 227,775.00 |
| Jun 30, 2025 | 227,775.00 |
| Jun 30, 2025 | 227,775.00 |
| Mar 31, 2025 | 3.79 Mn |
| Mar 31, 2025 | 3.79 Mn |
| Dec 31, 2024 | 194,000.00 |
| Dec 31, 2024 | 194,000.00 |
| Sep 30, 2024 | 3.88 Mn |
| Sep 30, 2024 | 3.88 Mn |
| Jun 30, 2024 | 3.88 Mn |
| Jun 30, 2024 | 3.88 Mn |
| Mar 31, 2024 | 2.49 Mn |
| Mar 31, 2024 | 2.49 Mn |